SHH Medulloblastoma
Showing 1 - 25 of 101
Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)
Active, not recruiting
- Brain Tumor
- +12 more
- Prexasertib
- +4 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 20, 2022
Medulloblastoma Trial in Memphis (procedure, drug, radiation)
Recruiting
- Medulloblastoma
- Surgical resection
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Sep 16, 2022
Brain and CNS Tumors Trial in Australia, Canada, United States (biological, drug, procedure, radiation)
Active, not recruiting
- Brain and Central Nervous System Tumors
- filgrastim
- +5 more
-
Durham, North Carolina
- +8 more
Dec 17, 2021
Based on Molecular Typing of Medulloblastoma in Children
Not yet recruiting
- Medulloblastoma, Childhood
- Prospective observational study, no intervention
- (no location specified)
Jun 4, 2022
Medulloblastoma, CNS Embryonal Tumors Trial in Canada, New Zealand, United States (Induction, Single Cycle Intensive
Recruiting
- Medulloblastoma
- Central Nervous System Embryonal Tumors
- Induction
- +2 more
-
Birmingham, Alabama
- +61 more
Feb 16, 2022
Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)
Active, not recruiting
- Brain and Central Nervous System Tumors
- Induction Chemotherapy
- +3 more
-
Palo Alto, California
- +5 more
Nov 29, 2022
Rare CNS Tumors Outcomes &Risk
Recruiting
- High Grade Meningioma
- +4 more
-
Bethesda, MarylandNational Cancer Institute (NCI)
Jul 6, 2022
Untreated Childhood Medulloblastoma Trial in Worldwide (drug, radiation, other)
Active, not recruiting
- Untreated Childhood Medulloblastoma
- Cisplatin
- +8 more
-
Birmingham, Alabama
- +177 more
Feb 25, 2022
Medulloblastoma Trial in Zürich (Sonidegib, Cisplatin, Lomustine)
Not yet recruiting
- Medulloblastoma
- Sonidegib
- +4 more
-
Zürich, SwitzerlandUniversity Hospital zurich
May 20, 2020
Histologically Confirmed Medulloblastoma, Activation of the Sonic Hedgehog (SHH) Pathway Trial in Worldwide (vismodegib,
Terminated
- Histologically Confirmed Medulloblastoma
- Activation of the Sonic Hedgehog (SHH) Pathway
-
Marseille, Bouches Du Rhône, France
- +14 more
May 20, 2019
Cerebellar Ataxia Trial in Giza (motor imaginary training, physical therapy training)
Completed
- Cerebellar Ataxia
- motor imaginary training
- physical therapy training
-
Giza, EgyptReham Alsakhawi
Aug 7, 2023
Neuroblastoma, Medulloblastoma Trial in United States (Nifurtimox, Cyclophosphamide, Topotecan)
Completed
- Neuroblastoma
- Medulloblastoma
- Nifurtimox
- +2 more
-
San Diego, California
- +14 more
Dec 28, 2022
Medulloblastoma, Childhood, Cognitive Impairment Trial (Metformin HCl (HCl) 500mg tablet, Placebo)
Recruiting
- Medulloblastoma, Childhood
- Cognitive Impairment
- Metformin hydrochloride (HCl) 500mg tablet
- Placebo
-
New Lambton Heights, New South Wales, Australia
- +15 more
Sep 7, 2022
Medulloblastoma Trial in Houston (Treatment with MTX110)
Recruiting
- Medulloblastoma
- Treatment with MTX110
-
Houston, TexasThe University of Texas Health Science Center at Houston
Jun 30, 2022
Using Next Generation Sequencing on Biological Samples to
Completed
- Holoprosencephaly
- NGS
-
Rennes, FranceCHU Rennes
Dec 6, 2021
CNS Tumors, Medulloblastoma Trial in Worldwide (Pomalidomide)
Active, not recruiting
- Central Nervous System Neoplasms
- Medulloblastoma
-
Stanford, California
- +24 more
Sep 28, 2022
Diffuse Intrinsic Pontine Glioma, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Switzerland, United States
Active, not recruiting
- Diffuse Intrinsic Pontine Glioma
- +4 more
- Fimepinostat
- Therapeutic Conventional Surgery
-
Los Angeles, California
- +18 more
Aug 16, 2022
Brain Tumor Treated With Cranial or Cranial-Spinal Radiation Trial in Toronto (Metformin, Placebo)
Completed
- Brain Tumor Treated With Cranial or Cranial-Spinal Radiation
- Metformin
- Placebo
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Sep 7, 2022
Medulloblastoma, CNS Tumor, Pediatric, Ependymoma Trial in Beijing
Recruiting
- Medulloblastoma
- +5 more
-
Beijing, Beijing, ChinaBeijing Tiantan Hosiptal
Jan 3, 2023
Ependymoma, Glioblastoma, Medulloblastoma Trial in Duarte (IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR
Recruiting
- Ependymoma
- +3 more
- IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 9, 2022